alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 79, Number 250 (Wednesday, December 31, 2014)]
[Notices]
[Page 78909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-30674]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Vehicle Safety Communications 5 (VSC5) 
Consortium

    Notice is hereby given that, on December 3, 2014, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Vehicle Safety 
Communications 5 (VSC5) Consortium (``VSC5 Consortium'') has filed 
written notifications simultaneously with the Attorney General and the 
Federal Trade Commission disclosing (1) the identities of the parties 
to the venture and (2) the nature and objectives of the venture. The 
notifications were filed for the purpose of invoking the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances.
    Pursuant to section 6(b) of the Act, the identities of the parties 
to the venture are: Ford Motor Company--Research and Innovation Center, 
Dearborn, MI; General Motors Company--Research and Development Center, 
Warren, MI; Honda R&D Americas, Inc., Southfield, MI; Hyundai-Kia 
America Technical Center, Inc., Superior Township, MI; Mazda Motor of 
America, Inc., Irvine, CA; Mercedes-Benz Research & Development North 
America, Inc., Sunnyvale, CA; Nissan Technical Center North America, 
Inc., Farmington Hills, MI; and Volkswagen/Audi of America, Auburn 
Hills, MI.
    The general area of VSC5 Consortium's planned activity is to engage 
in a collaborative effort in order to gain further knowledge and 
understanding of connected vehicle interactions and/or applications for 
vehicles that are intended to transform surface safety and mobility 
through a connected vehicle environment.

Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2014-30674 Filed 12-30-14; 8:45 am]
BILLING CODE P
Exhibit 32.2
------------

                    CERTIFICATION PURSUANT TO
                     18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Annual Report of BF Acquisition Group
III,  Inc.  (the "Company") on Form 10-KSB for the period  ending
September  30,  2004  as filed with the Securities  and  Exchange
Commission  on  the  date  hereof (the "Report"),  I,  Justin  P.
DiNorscia,  Treasurer  of the Company, certify,  pursuant  to  18
U.S.C.  1350, as adopted pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002, that:

     (1) The Report fully complies with the requirements  of Section
13(a) or 15(d) of the Securities Exchange Act  of  1934; and
     (2)  The  information contained in  the  Report  fairly
presents,  in all material respects, the financial condition  and
results of operations of the Company.

Dated: January 14, 2005


                            /s/ Justin P. DiNorscia
                            ----------------------------------------
                            Justin P. DiNorscia, Treasurer
                            BF Acquisition Group III, Inc.


<PAGE>
---




EXHIBIT 32
 
 CERTIFICATION PURSUANT TO
 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 In connection with the Amendment No. 1 to the annual report on Form 10-K (the “Report”) of Chembio Diagnostics, Inc. (the “Company”) for the year ended December 31, 2011, each of the undersigned Lawrence A. Siebert, the Chief Executive Officer of the Company, and Richard J. Larkin, the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigneds’ knowledge and belief:
 (1) This Form 10-K, as amended, for the year ended December 31, 2011 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 (2) The information contained in this Form 10-K, as amended, for the year ended December 31, 2011 fairly presents, in all material respects, the financial condition and results of operations of Chembio Diagnostics, Inc. for the periods presented therein.
 Dated:  January 3, 2013                                 /s/ Lawrence A. Siebert_______________________
 Lawrence A. Siebert, Chief Executive Officer
 Dated:  January 3, 2013                                  /s/ Richard J. Larkin_______________________
 Richard J. Larkin
 Chief Financial Officer
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2117 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 2117

 To provide for a limitation on availability of funds for Independent 
   Agencies, General Services Administration, Operating Expenses for 
                           fiscal year 2024.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 29, 2023

Mr. Biggs (for himself, Mr. Rosendale, Mr. Gaetz, Mr. Good of Virginia, 
   Mr. Roy, and Mr. Crane) introduced the following bill; which was 
   referred to the Committee on Oversight and Accountability, and in 
 addition to the Committee on Transportation and Infrastructure, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL

 
 To provide for a limitation on availability of funds for Independent 
   Agencies, General Services Administration, Operating Expenses for 
                           fiscal year 2024.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LIMITATION ON AVAILABILITY OF FUNDS FOR INDEPENDENT 
              AGENCIES, GENERAL SERVICES ADMINISTRATION, OPERATING 
              EXPENSES FOR FISCAL YEAR 2024.

    Notwithstanding any other provision of the law, amounts authorized 
to be appropriated or otherwise available for Independent Agencies, 
General Services Administration, Operating Expenses for fiscal year 
2024 may not exceed $49,440,000.
                                 <all>
```
Exhibit
      32(f)


CERTIFICATE
      PURSUANT TO 18 U.S.C. SECTION 1350


AS
      ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


FOR
      PPL
      ELECTRIC UTILITIES CORPORATION'S 10-Q FOR THE QUARTER ENDED SEPTEMBER 30,
      2007





In
      connection with the quarterly report on Form 10-Q of PPL Electric Utilities
      Corporation (the "Company") for the quarter ended September 30, 2007, as
      filed with the Securities and Exchange Commission on the date hereof (the
      "Covered Report"), I, the principal financial officer of the Company, pursuant
      to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, hereby certify that:





·
            The
                Covered Report fully complies with the requirements of Section 13(a)
                or
                15(d) of the Securities Exchange Act of 1934, as amended;
                and·
            The
                information contained in the Covered Report fairly presents, in all
                material respects, the financial condition and results of operations
                of
                the Company.











Date:  November
                1, 2007
            /s/  J.
                Matt Simmons, Jr.J.
                Matt Simmons, Jr.
              Vice
                President and Controller
              PPL
                Electric Utilities Corporation





A
      signed
      original of this written statement required by Section 906 has been provided
      to
      the Company and will be retained by the Company and furnished to the Securities
      and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM NUCLEAR
SUPPORT SERVICES, INC.'S FORM 10Q FOR THE PERIOD ENDED DECEMBER 31, 1995 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-END>                               DEC-31-1995
<CASH>                                         952,114
<SECURITIES>                                         0
<RECEIVABLES>                               19,178,742
<ALLOWANCES>                                 (586,594)
<INVENTORY>                                  1,175,877
<CURRENT-ASSETS>                            25,601,480
<PP&E>                                      13,503,210
<DEPRECIATION>                               7,139,316
<TOTAL-ASSETS>                              33,565,921
<CURRENT-LIABILITIES>                       18,276,484
<BONDS>                                      4,184,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         6,190
<OTHER-SE>                                   3,820,691
<TOTAL-LIABILITY-AND-EQUITY>                33,565,921
<SALES>                                              0
<TOTAL-REVENUES>                            21,056,009
<CGS>                                       17,891,289
<TOTAL-COSTS>                                 2,201624
<OTHER-EXPENSES>                                29,595
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             409,593
<INCOME-PRETAX>                                523,908
<INCOME-TAX>                                   209,563
<INCOME-CONTINUING>                            314,345
<DISCONTINUED>                               (143,181)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   171,164
<EPS-PRIMARY>                                      .08
<EPS-DILUTED>                                      .08
        

</TABLE>
Exhibit 32.1

















906 CERTIFICATION OF CERTIFYING OFFICER





CERTIFICATION OF CHIEF EXECUTIVE OFFICER


AND CHIEF FINANCIAL OFFICER


PURSUANT TO 18 U.S.C. SECTION 1350





In connection with the accompanying Yearly Report On Form 10-K of Exclusive Apparel, Inc. for the Year Ended December 31, 2010, I, Georgette Mathers, Chief Executive Officer and Chief Financial Officer of Exclusive Apparel, Inc. hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:





1.   Such Yearly Report on Form 10-K for the year ended December 31, 2010, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.   The information contained in such Yearly Report on Form 10-K for the year ended December 31, 2010, fairly presents, in all material respects, the financial condition and results of operations of Exclusive Apparel, Inc.





Dated:  February 9, 2011





EXCLUSIVE APPAREL, INC.








By:/s/ Georgette Mathers


Chief Executive Officer


Chief Financial Officer and


Chief Accounting Officer





This certification accompanies this report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purpose of Section 18 of the Securities Exchange Act of 1934, as amended.





A signed original of this written statement required by Section 906, another document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Exclusive Apparel, Inc. and will be retained and furnished to the Securities and Exchange Commission or its staff upon request.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01).                    

*Date:*                         January 29, 2015.                    

*Time:*                         12 p.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 5601 Fisher Lane, Rockville, MD 20892 (Telephone Conference Call).                    

*Contact Person:*                         Thomas F. Conway, Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 2217, 6700-B Rockledge Dr., MSC-7616, Bethesda, MD 20892-7616, 301-451-4573,                         *thomas.conway@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: December 31, 2014.

David Clary,

                        Program Analyst,                         *Office of Federal Advisory Committee Policy.*

[FR Doc. 2015-00042 Filed 1-7-15; 8:45 am]

BILLING CODE 4140-01-P
##### 



SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
 FORM 6-K Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934 For the month of January 2005
    
    Commission File Number: 001-15014
 Sun Life Financial Inc.  
 (Translation of registrants name into English)
  150 King Street West, Toronto, Ontario, M5H 1J9
 
 (Address of principal executive offices)
 [Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.] Form 20-F o
    
    Form 40-F þ
 [Indicate be check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.] Yes o
    
    No þ
 If Yes is marked, indicate below the file number assigned to the registrant
in connection with Rule 12g3-2(b): 82-N/A    Exhibit99.1
    
    Earnings Press Release issued on
January 27, 2005




---



##### 



SIGNATURE Pursuant to the requirement of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized. Sun Life Financial Inc.
     (Registrant)Date: January 27, 2005
    By
    
    /s/ Thomas A. BogartThomas A. Bogart,Executive Vice-President and Chief Legal Officer
alpineexh106.htm


Amendment 10.6











FIRST AMENDMENT TO LICENSING AGREEMENT





 





THIS FIRST AMENDMENT TO LICENSING AGREEMENT (the “Amended Agreement”), dated and effective as of August 4, 2015 (the “Effective Date”), is made by Alpine 4 Technologies Ltd. (formerly Alpine 4 Automotive Technologies Ltd.), a Delaware corporation, (“Licensee”) and AutoTek Incorporated, an Arizona corporation (“Licensor”).   Licensee and Licensor may hereinafter also be referred to individually as a “Party” and collectively as the “Parties.”





 





BACKGROUND





 


A.  On August 5, 2014, the Licensee and Licensor entered into the initial Licensing Agreement (the “Original Agreement”) relating to the license by the Licensor of certain rights to certain confidential and proprietary technology including software code (the “Source Code”), as more fully described in the Original Agreement (the “Existing Technology”).


 


B.   Licensor and Licensee have worked to close the purchase by Licensee of the Source Code, which is subject to the approval by the shareholders of Licensor, and have prepared and filed with the U.S. Securities and Exchange Commission a registration statement on Form S-4 relating to the obtaining of consent of shareholders of the Licensor, which registration statement had not been declared effective as of the date of this Amended Agreement.


 


C.  Licensee and Licensor now desire to amend the Original Agreement to extend the termination deadline of the Original Agreement.










AGREEMENT





 


For good and valuable consideration, the sufficiency of which is hereby acknowledged by the parties, the Parties agree as follows:









Section 15 of the Original Agreement is hereby amended to read as follows:







Section 15.  TERM; TERMINATION.  The term of this Agreement shall be commencing on 8:00 a.m., EST, on the Effective Date and shall end on 11:59 p.m., EST, on the date of the earlier to occur of:  (A) the execution and closing of the Definitive Purchase Agreement by the parties and providing for the acquisition of the Source Code from AUTOTEK, or (B) on 8:00 a.m., EST, on the second annual anniversary of the Effective Date.













IN WITNESS WHEREOF, the parties, intending to be legally bound hereby, have each caused to be affixed hereto its or his/her hand the day indicated.


 


LICENSOR


AutoTek Incorporated, an Arizona corporation







By: /s/ Richard Battaglini                                                                


Name:  Richard Battaglini


Title:    President, CEO


Date: August 4, 2015







LICENSEE


Alpine 4 Technologies Ltd., a Delaware corporation












By:  Kent Wilson                                                                


Name: Kent Wilson


Title:   Chief Executive Officer


Date: August 4, 2015
#### In the Matter of Diane Word, Petitioner, v Barbara G. Zambelli, as Justice of the Supreme Court of the State of New York, et al., Respondents.

[870 NYS2d 798

Proceeding pursuant to CPLR article 78 in the nature of mandamus to compel the re*746spondent Barbara G. Zambelli, a Justice of the Supreme Court, Westchester County, to give “due process review” to the petitioner’s motion for leave to reargue and/or renew dated January 2, 2007, and motion for leave to renew dated May 7, 2007, and application by the petitioner to prosecute the proceeding as a poor person.

Ordered that the application to prosecute the proceeding as a poor person is granted to the extent that the filing fee imposed by CPLR 8022 (b) is waived, and the application is otherwise denied as academic; and it is further,

Adjudged that the petition is denied and the proceeding is dismissed on the merits, without costs or disbursements.

The extraordinary remedy of mandamus will lie only to compel the performance of a ministerial act and only when there exists a clear legal right to the relief sought (see *Matter of Legal Aid Socy. of Sullivan County v Scheinman,*53 NY2d 12, 16 [1981]). The petitioner has failed to demonstrate a clear legal right to the relief sought. Fisher, J.E, Balkin, McCarthy and Leventhal, JJ, concur.
#### UNITED STATES of America, Plaintiff-Appellee v. Maria Del Carmen HERNANDEZ-AGUIRRE, Defendant-Appellant.

No. 07-50139

Summary Calendar.

United States Court of Appeals, Fifth Circuit.

Dec. 28, 2007.

Joseph H. Gay, Jr., Assistant U.S. Attorney, U.S. Attorney’s Office, Western *734District of Texas, San Antonio, TX, for Plaintiff-Appellee.

Donna F. Coltharp, Federal Public Defender’s Office, Western District of Texas, San Antonio, TX, for Defendant-Appellant.

Before KING, DAVIS, and CLEMENT, Circuit Judges.

PER CURIAM: *

Maria Del Carmen Hernandez-Aguirre (Hernandez) appeals her sentence for illegal reentry after deportation in violation of 8 U.S.C. § 1326. She contends that the 46-month sentence imposed was unreasonable because it was greater than necessary to meet the sentencing goals of 18 U.S.C. § 3553(a). Specifically, Hernandez argues that the sentence failed to account for the fact that her prior felony drug trafficking offense occurred when she was a teenager, this was her only prior offense, she entered the United States to see her eight-year old daughter, and she was not a danger to the public or likely to commit future crimes.

Where the district court exercises its discretion to impose a sentence within a properly calculated guideline range, the sentence is presumptively reasonable, and this court may infer that the district court considered all the factors for a fair sentence set forth in the Guidelines. *See Rita v. United States,*— U.S. -, -- -, 127 S.Ct. 2456, 2462-70, 168 L.Ed.2d 203 (2007); *United States v. Alonzo,*435 F.3d 551, 554 (5th Cir.2006). Here, the record reflects that the district court considered Hernandez’s arguments, the recommendations of the presentence report, the applicable guideline range, and the § 3553(a) factors. Hernandez has failed to demonstrate that the district court clearly erred in exercising its broad sentencing discretion by imposing a sentence that failed to account for sentencing factors entitled to significant weight, gave significant weight to improper or irrelevant factors, or represented a clear error of judgment in balancing the sentencing factors. *See United States v. Nikonova,*480 F.3d 371, 376 (5th Cir.), *cert. denied,*- U.S. -, 128 S.Ct. 163, 169 L.Ed.2d 112 (2007).

In light of *Apprendi v. New Jersey,*530 U.S. 466, 120 S.Ct. 2348, 147 L.Ed.2d 435 (2000), Hernandez challenges the constitutionality of § 1326(b)’s treatment of prior felony and aggravated felony convictions as sentencing factors rather than elements of the offense that must be found by a jury. This court has held that this issue is “fully foreclosed from further debate.” *United States v. Pinedas-Arrellano,*492 F.3d 624, 625 (5th Cir.2007), *cert. denied*— U.S. -, 128 S.Ct. 872, 169 L.Ed.2d 737 (2008).

Accordingly, the district court’s judgment is AFFIRMED.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.